Innovative Industrial PropertiesIIPR
Recorded

Innovative Industrial Properties 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration32 minParticipants10

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Hello, everyone. Thank you for joining us, and welcome to the Innovative Industrial Properties Inc. Q3 2026 earnings call. After today's prepared remarks, we will host a question-and-answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. I will now hand the conference over to Eli Kanter, Director of Finance.

Eli KanterDirector of Finance

Thank you for joining the call. Presenting today are Alan Gold, Executive Chairman, Paul Smithers, President and Chief Executive Officer, David Smith, Chief Financial Officer, and Ben Regin, Chief Investment Officer. Before we begin, I'd like to remind everyone that some of the statements made during today's conference call, including statements regarding potential lease transactions that are subject of letters of intent, are forward-looking statements within the meaning of the Safe Harbor of the Private Securities Litigation Reform Act of 1995, and subject to risks and uncertainties. Actual results may differ materially, and we refer you to our SEC filings, specifically our most recent reports on Forms 10-K and 10-Q, for a full discussion of risk factors that could cause actual results to differ materially from those contained in the forward-looking statements.

Eli KanterDirector of Finance

We are not obligated to update or revise any forward-looking statements, whether due to new information, future events, or otherwise, except as required by law. In addition, on today's call, we will discuss certain non-GAAP financial information, such as FFO, normalized FFO, AFFO, and Adjusted EBITDA. You can find this information together with reconciliations to the most directly comparable GAAP financial measures, which is available on the investor relations section of our website at www.innovativeindustrialproperties.com, in our earnings release issued yesterday, as well as in our eight-K filed with the SEC. I'll now hand the call over to Alan.

Alan GoldExecutive Chairman

Thanks, Eli. Good morning, everyone, and thank you for joining our third quarter 2026 earnings call. The third quarter marked another period of significant execution for us, highlighted by the continued expansion of our life science investments, strong leasing activity across our existing portfolio, significant growth in our AFFO per share versus the second quarter, and disciplined capital allocation. Most notably, in September, we entered into a $245 million mezzanine loan commitment as a member of a lender syndicate to IQHQ for Alewife Park, a premier life science campus in Cambridge, Massachusetts, one of the country's leading life science markets. This highly accretive investment builds on our existing relationship with IQHQ and is expected to generate an average interest rate of approximately 15.8% over the term of the loan.

Alan GoldExecutive Chairman

Together with our original $270 million commitment to IQHQ and an additional $30 million investment through the preferred equity structure in September, we have now committed approximately $545 million to life sciences. Upon full funding, our life science investments are projected to account for approximately 26% of our total annualized income. We believe the current market environment continues to present compelling opportunities to deploy capital into the life science sector at attractive entry points. Our recent investments reflect both our confidence in the sector's long-term fundamentals and our disciplined approach to expanding our platform. At the same time, our team delivered strong leasing results across our cannabis portfolio. During the quarter, we executed new leases at six properties totaling approximately 604,000 sq ft, followed by an additional 270,000 sq ft lease subsequent to quarter end.

Alan GoldExecutive Chairman

Together, these transactions represent approximately 874,000 sq ft of gross leasing activity since the beginning of the third quarter, bringing our total gross leasing activity year to date to approximately 1.3 million square feet across 12 properties, or 15% of our total portfolio. Importantly, we continue to see strong interest across our portfolio, reinforcing our confidence in the underlying value of our real estate, with an active pipeline of additional transactions. We remain focused on building upon this momentum, driving occupancy, and positioning the portfolio for strong long-term performance. We delivered strong quarterly earnings as well, with AFFO per share up 7% sequentially to $1.96 per share, as we had continued recoveries of past-due rents from certain tenants. On the capital front, and subsequent to quarter end, we completed a $54 million public offering of our 9.25% Series B Preferred Stock.

Alan GoldExecutive Chairman

We intend to use the net proceeds to fund all or a portion of our remaining commitment under our Alewife Park mezzanine loan commitment and for general corporate purposes. This transaction further demonstrates our ability to access the capital markets to fund attractive, accretive investments and support the continued growth and diversification of our platform. Taken together, we believe these accomplishments underscore our strong management team and ability to deploy capital into accretive investments while actively managing and maximizing the value of our existing portfolio. We believe the combination of our growing life science investments, leasing momentum, and financial flexibility positions us for future growth and long-term shareholder value creation. With that, I'll turn the call over to Paul.

Paul SmithersPresident and CEO

Paul? Thanks, Alan. At the federal level, cannabis reform continued to advance.

Paul SmithersPresident and CEO

Over the summer, the DEA completed its hearing on the proposed rescheduling of marijuana more broadly from Schedule I to Schedule III. While the proceedings remain subject to further administrative review, and the timing and outcome of any final decision remains uncertain, we believe federal reform has the potential to provide meaningful benefits to operators, including improved economics and broader access to traditional sources of capital. We have also seen encouraging investment and M&A activity across the cannabis industry, with established operators pursuing expansion in attractive markets, including Pennsylvania, Ohio, New York, and Colorado. We believe this activity signals that well-capitalized operators remain committed to strategic growth and are actively investing in markets with strong long-term fundamentals. While financial challenges persist for certain operators, we continue to take decisive action across our portfolio.

Paul SmithersPresident and CEO

During the quarter, we regained possession of properties previously leased to Parallel, PharmaCann, and The Cannabist Company. These transitions allow us to pursue leasing opportunities, strengthen our tenant base, and improve overall portfolio performance. Turning to the state level, Florida recently approved 22 additional vertically integrated medical cannabis licenses, representing a meaningful expansion of one of the country's largest medical cannabis markets. We believe the addition of new operators creates opportunities for further investment and expansion in the state, including demand for mission-critical real estate. More broadly, regulated cannabis markets continue to reach significant milestones. Massachusetts surpassed $10 billion in cumulative adult-use cannabis sales in September, while California has generated nearly $8.4 billion in cannabis tax revenue since 2018. These achievements underscore the scale and economic significance of established cannabis markets, even as operators continue to navigate a challenging environment.

Paul SmithersPresident and CEO

With that, I'll turn the call over to Ben to provide additional details on our portfolio activities.

Ben ReginCIO

Thanks, Paul. Starting with our investment activity, we expanded our life science portfolio this quarter, closing on $275 million in new commitments. We invested an additional $30 million in IQHQ preferred equity and closed on a $245 million mezzanine loan commitment for Alewife Park, our premier life science campus in Cambridge, Massachusetts. Alewife Park is a 27-acre campus comprised of three existing buildings totaling 392,000 sq ft and two pad-ready sites with up to 364,000 sq ft of additional development potential. The existing buildings are 78% leased to Lila Sciences, an AI-enabled scientific discovery company. In addition to the approximately $800 million invested in the campus prior to our investment, we believe the quality of the real estate, established tenancy, and location within one of the country's leading life science markets provide a strong foundation for our accretive investment.

Ben ReginCIO

Under the terms of our commitment, we funded approximately $111 million at closing, with the remaining $134 million expected to be funded through the fourth quarter of 2027. The loan is expected to generate an average interest rate of approximately 15.8% over the term. The financing will support the completion, tenant improvements, lease-up, and stabilization of the campus. We believe the current environment continues to present attractive entry points in life science real estate, specifically for high-quality assets in the core life science markets of Boston, San Diego, and the Bay Area. According to JLL, these three markets, along with Raleigh-Durham, have seen combined demand increase 44% year-over-year to nearly 8 million square feet in Q1 2026, driven by improved biotech funding conditions and biomanufacturing reshoring.

Ben ReginCIO

Against this backdrop, we are actively growing our acquisition pipeline, seeing opportunities to invest in high-quality assets in these core markets at attractive risk-adjusted returns. Turning to leasing, we had our most active quarter to date, with substantial activity across multiple properties and markets. During the third quarter, we executed new leases totaling 604,000 sq ft across six properties located in California, Massachusetts, New York, Ohio, and Washington. That momentum continued into the fourth quarter with an additional 270,000 sq ft lease for a property located in Pennsylvania, bringing total leasing activity since July to 874,000 sq ft. Beyond these completed transactions, we have a pipeline of additional transactions we believe are progressing toward execution.

Ben ReginCIO

We have agreements in place covering three properties in Colorado totaling 72,000 sq ft, subject to the license transfer and regulatory approval process, as well as agreements across three properties previously leased to 4Front Ventures, totaling another 374,000 sq ft. In total, these agreements cover an additional 446,000 sq ft beyond the leases already executed. These agreements remain subject to customary due diligence, including licensing and regulatory approvals, and there can be no assurance that these discussions or negotiations will result in executed leases. With that, I'll turn the call over to David.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day